Literature DB >> 700895

Interferon and spontaneous cytotoxicity in man. I. Enhancement of the spontaneous cytotoxicity of peripheral lymphocytes by human leukocyte interferon.

S Einhorn, H Blomgren, H Strander.   

Abstract

A purified preparation of human leukocyte interferon used at this hospital in the treatment of malignant diseases was tested for its ability to modify the spontaneous cytotoxicity of peripheral lymphocytes from healthy donors. The inhibitory effect of allogeneic lymphocytes on the (3H)thymidine incorporation of a lymphoblastoid cell line, Raji, was augmented by the presence of interferon or by pretreatment of the lymphocytes with interferon. This form of pretreatment also increased lymphocytes' capacity for reducing the number of surface-adherent tumor cells in a microassay. Moreover, lymphocytes treated with interferon exhibited an enhanced cytotoxic capacity for target cells on incubation with such cells labelled with 51CR.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 700895     DOI: 10.1002/ijc.2910220407

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  35 in total

1.  Cytotoxicity of human peripheral blood T-lymphocyte clones activated by hepatitis B virus surface antigen.

Authors:  A A Hakim
Journal:  Experientia       Date:  1985-12-15

2.  Effect of recombinant gamma interferon on natural killer cell activity in patients with gastric cancer.

Authors:  Y Kuwahara; K Kusugami; K Morise; K Shimokata
Journal:  Gastroenterol Jpn       Date:  1987-08

Review 3.  Viewpoint on the impact of interferon in the treatment of multiple myeloma: benefit for a small proportion of patients?

Authors:  J Bladé; J Esteve
Journal:  Med Oncol       Date:  2000-05       Impact factor: 3.064

4.  Influence of low doses of an oxazaphosphorine on natural killer activity of human lymphocytes.

Authors:  H Blomgren
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

5.  Anticipatory immune changes in women treated with chemotherapy for ovarian cancer.

Authors:  M Lekander; C J Fürst; S Rotstein; H Blomgren; M Fredrikson
Journal:  Int J Behav Med       Date:  1995

6.  The CySF-L2 factor from dialysable human leucocyte extract activates natural killer cytotoxicity by induction of interferon gamma.

Authors:  I Doelker; F A Anderer
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

7.  Regulation of natural and antibody-dependent cellular cytotoxicity by staphylococcal enterotoxin A.

Authors:  I Kimber; T Bakács; M Moore
Journal:  Clin Exp Immunol       Date:  1983-10       Impact factor: 4.330

8.  Evaluation of the natural killer cell-interferon system in patients with mid-gut carcinoid tumours treated with leucocyte interferon.

Authors:  K Funa; G V Alm; L Rönnblom; K Oberg
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

9.  Influence of human interferon-alpha therapy on cytotoxic functions of blood lymphocytes. Studies on lectin-dependent cellular cytotoxicity, antibody-dependent cellular cytotoxicity, and natural killer cell activity.

Authors:  S Einhorn; H Blomgren; H Strander; J Wasserman
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

10.  Lectin-binding characteristics of human natural killer cells.

Authors:  B M Vose; G Blackledge; D Crowther; J Gallaher
Journal:  Immunology       Date:  1982-07       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.